Company details, activities, locations, contacts, financials and reviews for RNA Advisors.
Main company details for RNA Advisors.
RNA Advisors will provide strategic insights, financial modeling, and transaction advisory support to help Sarcomatrix secure funding, navigate preclinical and clinical development, and maximize the market potential of its therapies. This collaboration is a key step in Sarcomatrix’s long-term plan to bring new hope to patients with muscle-related diseases.
“We’re at a critical point in our growth, moving our pipeline closer to clinical development,” said David Craig, CEO of Sarcomatrix Therapeutics. “Partnering with RNA Advisors gives us the expertise we need to sharpen our financial strategy, build investor confidence, and set our programs up for lasting success. Their deep understanding of the life sciences industry will be invaluable as we move forward.”
RNA Advisors has extensive experience helping biotech companies with valuations, mergers and acquisitions, licensing deals, and corporate strategy. With a strong track record of advising life sciences firms on capital formation and deal execution, RNA Advisors is well-equipped to support Sarcomatrix’s mission of bringing transformative therapies to patients
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for RNA Advisors on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
